Skip to content
Open access

The immunophenotype and proviral landscape of HIV-infected CD4 T cells during antiretroviral therapy

Aug 2026 · Proceedings of the National Academy of Sciences of the United States of America · Vol 123 · 0 citations · 90 references
Medicine

TL;DR

This work presents a high-resolution immunophenotypic map of the HIV reservoir, highlighting the diversity of infected cells and suggesting that subset-specific processes govern proviral fate.

Abstract

Significance The persistence of HIV in CD4+ T cells during antiretroviral therapy (ART) remains a barrier to cure. To study this reservoir, we developed an open-source DAb-seq platform that sequences proviral DNA and surface epitopes in single cells and profiled ~527,000 CD4 T cells from individuals on ART. HIV-infected cells were enriched in memory T cell subsets, and surface protein differences between HIV+ and HIV− cells mirrored this distribution. Although memory T cells contained most infected cells, proviruses with more genomic regions detected were disproportionately enriched in Naïve, Transitional memory, and Regulatory subsets, suggesting that subset-specific processes govern proviral fate. This work presents a high-resolution immunophenotypic map of the HIV reservoir, highlighting the diversity of infected cells.

Read PDF

Similar papers

Review Open access Sep 2026

HIV Proviral DNA: Clinical Applications, Drug Resistance, and the HIV Reservoir

Abstract: Antiretroviral therapy has rendered HIV a manageable chronic infection, but integrated proviral DNA within long-lived CD4+ memory T cells persists indefinitely and constitutes both a barrier to cure and an archive of the patient’s virologic history. Genotypic resistance testing performed on proviral DNA from...

Brian Harting · 0 citations
Open access Oct 2026

A Bispecific Biologic That Robustly Reverses HIV-1 and SIV Latency

T4IL15Δ is engineered, a bispecific biologic that selectively delivers IL-15 signaling to memory CD4 T cells, with minimal off-target stimulation, and provides a robust reactivation platform that could complement other reservoir-elimination strategies toward an HIV-1 cure.

Yao-Xing Huang, M. Nair, J. Yu et al. · 0 citations
Open access Oct 2026

HIV remodels germinal centers through T follicular helper cell loss

T follicular helper cells (Tfh) within germinal centers are among the most permissive cells for HIV infection and serve as a critical part of the viral reservoir. Given the key role of Tfh in affinity maturation and the production of plasma cells and memory B cells, an understanding of this critical viral reservoir is...

D. Jacobs, F. S. Abdool, Lily Pohlenz et al. · 0 citations
Open access Aug 2026

Immunosenescence and immune dysfunction in treated and untreated HIV-infected individuals

Background and objectives To better understand the immune alterations resulting from HIV infection and antiretroviral therapy, we analysed various markers of immunosenescence and immune dysregulation in HIV-1-infected individuals on prolonged combination antiretroviral therapy (cART) (HIV+ART+), treatment-naïve HIV+ in...

A. Unissa, A. Madheswaran, A. Inbanathan et al. · 0 citations
Sep 2026

Functional T Cell Responses Are Associated With Prolonged HIV Control After Treatment Interruption.

Findings indicate that high pre-ATI Gag-specific IFN-γ and CD8+ T cell proliferation responses were associated with an increase in the duration of virological control after stopping ART, supporting a role for CD8+ T cells in sustaining virological control.

Anders B. Andersen, A. K. Juhl, J. Gunst et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.